Similar articles for PMID: 11390999

Year	Number of Results
1997	1
1999	1
2001	7
2002	4
2003	5
2004	8
2005	6
2006	4
2007	4
2008	1
2017	1
2024	0

1

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse.

Shi FD, Flodstrom M, Balasa B, Kim SH, Van Gunst K, Strominger JL, Wilson SB, Sarvetnick N. Shi FD, et al. Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6777-82. doi: 10.1073/pnas.121169698. Proc Natl Acad Sci U S A. 2001. PMID: 11390999 Free PMC article.

2

Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells.

Araujo LM, Lefort J, Nahori MA, Diem S, Zhu R, Dy M, Leite-de-Moraes MC, Bach JF, Vargaftig BB, Herbelin A. Araujo LM, et al. Eur J Immunol. 2004 Feb;34(2):327-35. doi: 10.1002/eji.200324151. Eur J Immunol. 2004. PMID: 14768037 Free article.

3

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A. Sharif S, et al. Nat Med. 2001 Sep;7(9):1057-62. doi: 10.1038/nm0901-1057. Nat Med. 2001. PMID: 11533711

4

The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.

Cardell SL. Cardell SL. Clin Exp Immunol. 2006 Feb;143(2):194-202. doi: 10.1111/j.1365-2249.2005.02942.x. Clin Exp Immunol. 2006. PMID: 16412042 Free PMC article. Review.

5

The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L. Hong S, et al. Nat Med. 2001 Sep;7(9):1052-6. doi: 10.1038/nm0901-1052. Nat Med. 2001. PMID: 11533710

6

Transient chemokine receptor blockade does not prevent, but may accelerate type 1 diabetes in prediabetic NOD mice.

Seifarth C, Mack M, Steinlicht S, Hahn EG, Lohmann T. Seifarth C, et al. Horm Metab Res. 2006 Mar;38(3):167-71. doi: 10.1055/s-2006-925221. Horm Metab Res. 2006. PMID: 16673207

7

Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions.

Aslanian AM, Chapman HA, Charo IF. Aslanian AM, et al. Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):628-32. doi: 10.1161/01.ATV.0000153046.59370.13. Epub 2004 Dec 9. Arterioscler Thromb Vasc Biol. 2005. PMID: 15591216

8

The role of innate immunity in autoimmunity.

Bach JF, Bendelac A, Brenner MB, Cantor H, De Libero G, Kronenberg M, Lanier LL, Raulet DH, Shlomchik MJ, von Herrath MG. Bach JF, et al. J Exp Med. 2004 Dec 20;200(12):1527-31. doi: 10.1084/jem.20042110. J Exp Med. 2004. PMID: 15611284 Free PMC article.

9

CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.

Mi QS, Meagher C, Delovitch TL. Mi QS, et al. Novartis Found Symp. 2003;252:146-60; discussion 160-4, 203-10. Novartis Found Symp. 2003. PMID: 14609217 Review.

10

Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.

Yoshimoto T, Min B, Sugimoto T, Hayashi N, Ishikawa Y, Sasaki Y, Hata H, Takeda K, Okumura K, Van Kaer L, Paul WE, Nakanishi K. Yoshimoto T, et al. J Exp Med. 2003 Apr 21;197(8):997-1005. doi: 10.1084/jem.20021701. Epub 2003 Apr 14. J Exp Med. 2003. PMID: 12695491 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

40 results

Results by year